Precision Biosciences DTIL
NASDAQ DTIL
$9.15 -0.35 (-3.68%)
At close: Nov 11, 2026 · 4:00 PM EST

Precision Biosciences (DTIL) Non-Current Deferred Revenue (2018 - 2025)

Updated

Precision Biosciences (DTIL) recorded Non-Current Deferred Revenue of $19.96 million in fiscal Q3 2025 (quarter ended Sep 30, 2025), down 24.9% from $26.58 million a year earlier and down 1.3% from the prior quarter.

Analysis

Precision Biosciences (DTIL) Non-Current Deferred Revenue (2018 - 2025) Analysis & Trends

At the end of FY2024 (ended Dec 31, 2024), Precision Biosciences reported Non-Current Deferred Revenue of $23.3 million, down 68.1% from FY2023.

  • Annual Non-Current Deferred Revenue has a five-year compound annual growth rate of -18.8% (FY2019 to FY2024).
  • Across earlier fiscal years, Non-Current Deferred Revenue came in at $73.08 million in FY2023 (-11.8%), $82.87 million in FY2022 (+23.7%), $67.02 million in FY2021 (+24.3%) and $53.93 million in FY2020 (-18.2%).
  • The fiscal Q3 2025 figure is the lowest quarterly Non-Current Deferred Revenue in data going back to fiscal Q4 2018.
  • On a year-over-year basis, Non-Current Deferred Revenue has declined for ten consecutive quarters, with an average decline of 42.7% over the last eight quarters.
  • Peak year-over-year performance for Non-Current Deferred Revenue in the last five years was growth of 99.0% in fiscal Q1 2021, against a decline of 72.6% in fiscal Q1 2025 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $20.23 million (Q2 2025), $20.5 million (Q1 2025) and $23.3 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Precision Biosciences 264.98 Mn -121.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 19.96 Mn
Jun 30, 2025 20.23 Mn
Mar 31, 2025 20.50 Mn
Dec 31, 2024 23.30 Mn
Sep 30, 2024 26.58 Mn
Jun 30, 2024 26.78 Mn
Mar 31, 2024 74.77 Mn
Dec 31, 2023 73.08 Mn
Sep 30, 2023 73.90 Mn
Jun 30, 2023 78.08 Mn
Mar 31, 2023 82.76 Mn
Dec 31, 2022 82.87 Mn
Sep 30, 2022 90.51 Mn
Jun 30, 2022 104.05 Mn
Mar 31, 2022 65.74 Mn
Dec 31, 2021 67.02 Mn
Sep 30, 2021 71.84 Mn
Jun 30, 2021 75.30 Mn
Mar 31, 2021 131.24 Mn
Dec 31, 2020 53.93 Mn
API Access

Precision Biosciences Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=DTIL&period=max&api_key=YOUR_API_KEY